EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chlamydia trachomatis restricts signaling through NOD2 until late in the pathogen’s developmental cycle

Grace Overman, Iris Loeckener, Zachary Williford, Sung Davis, Aissata Diallo, Josie Blair, Beate Henrichfreise iD, George W Liechti iD

Infection and Immunity · 2026

DOI: 10.1128/iai.00472-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infection and Immunity, 2026. Verfasst von Grace Overman und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Uniformed Services University, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Nod2 Signaling Adaptor Protein, Chlamydia trachomatis, Signal Transduction, Chlamydia Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Uniformed Services University of the Health Sciences, NIGMS NIH HHS, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pathogenic chlamydial species restrict their peptidoglycan (PG) to the division septum of their replicative forms. PG is a microbe-associated molecular pattern, and two of its major pattern recognition receptors in human cells are nucleotide-binding oligomerization domain-containing proteins 1 and 2 (NOD1 and NOD2, respectively). It has been proposed that this unique morphological feature is evidence of pathoadaptation by the microbe, permitting PG-dependent cell division while also reducing the bacterium’s recognition by innate immune receptors. Chlamydia trachomatis -infected cells activate NOD1 signaling within 8–12 hours of exposure to the bacterium, roughly coinciding with the microbe’s transition from its infectious to replicative forms. Here, we report that, unlike NOD1 signaling, Chlamydia -induced NOD2 signaling does not occur until later in the pathogen’s developmental cycle. Both C. trachomatis and the related murine pathogen Chlamydia muridarum signal late in infection in HEK293 reporter cell lines expressing either human or murine-derived NOD2 receptors. NOD2 signaling can be modulated by disruption of the chlamydial amidase enzyme, AmiA CT , interrupting the microbe’s developmental cycle, and treatment with inhibitors of lipooligosaccharide or PG biosynthesis/assembly. These results mirror prior observations with Chlamydia-induced TLR9 signaling, leading us to hypothesize that Chlamydia-induced NOD2 signaling results from lytic events that occur sporadically during the transition between the pathogen’s developmental forms. Given our finding that pre-treating cells with NOD2-stimulatory ligands reduces chlamydial inclusion size and delays the developmental cycle, we hypothesize that the microbe preferentially degrades its PG during development to reduce the generation of NOD2 ligands.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nod2 Signaling Adaptor ProteinChlamydia trachomatisSignal TransductionChlamydia InfectionsHumansAnimalsMiceNod1 Signaling Adaptor ProteinChlamydia muridarumHost-Pathogen InteractionsPeptidoglycan

Stichwörter der Autor:innen

ChlamydiaNOD2innate immunitypathoadaptationpeptidoglycanpersistence

Substanzen

Nod2 Signaling Adaptor ProteinNOD2 protein, humanNod1 Signaling Adaptor ProteinPeptidoglycan

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Uniformed Services University, Bethesda, Maryland, USA.
  • Henry Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA.
  • Institute for Pharmaceutical Microbiology, University of Bonn, Bonn, Germany.

ORCID-Profile: Beate Henrichfreise, George W Liechti

Förderung

  • Uniformed Services University of the Health Sciences
  • NIGMS NIH HHS
  • Deutsche Forschungsgemeinschaft
  • National Institute of General Medical Sciences

Zitieren

APA

Overman, G., Loeckener, I., Williford, Z., Davis, S., Diallo, A., Blair, J., Henrichfreise, B., & Liechti, G. W. (2026). Chlamydia trachomatis restricts signaling through NOD2 until late in the pathogen’s developmental cycle. Infection and Immunity. https://doi.org/10.1128/iai.00472-25

Vancouver

Overman G, Loeckener I, Williford Z, Davis S, Diallo A, Blair J, et al. Chlamydia trachomatis restricts signaling through NOD2 until late in the pathogen’s developmental cycle. Infection and Immunity. 2026. doi:10.1128/iai.00472-25

BibTeX
@article{Overman2026,
  author = {Overman, Grace and Loeckener, Iris and Williford, Zachary and Davis, Sung and Diallo, Aissata and Blair, Josie and Henrichfreise, Beate and Liechti, George W},
  title = {Chlamydia trachomatis restricts signaling through NOD2 until late in the pathogen’s developmental cycle},
  journal = {Infection and Immunity},
  year = {2026},
  doi = {10.1128/iai.00472-25}
}
Kostenlos starten →